Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. (Q47836020)

6 February 2018

title

Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. (English)

1 reference

6 February 2018

main subject

phase III clinical trial

0 references

0 references

1 reference

1 reference

3

1 reference

6 February 2018

author name string

Vasee Moorthy

series ordinal

1

1 reference

6 February 2018

Zarifah Reed

series ordinal

2

1 reference

6 February 2018

WHO Study Group on Measures of Malaria Vaccine Efficacy

series ordinal

4

1 reference

6 February 2018

language of work or name

English

0 references

publication date

2 February 2007

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

25

1 reference

6 February 2018

issue

28

1 reference

6 February 2018

page(s)

5115-5123

1 reference

6 February 2018

Attributable fraction estimates and case definitions for malaria in endemic areas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Pre-erythrocytic malaria vaccines: towards greater efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Modeling a field trial of the RTS,S/AS02A malaria vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Towards a blood-stage vaccine for malaria: are we following all the leads?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Progress and challenges for malaria vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Update on the clinical development of candidate malaria vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Malaria vaccine developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

Indicators of life-threatening malaria in African children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

inferred from DOI database lookup

7 January 2021

based on heuristic

The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.085

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.01.085

1 reference

6 February 2018

PubMed ID

17577487

1 reference

6 February 2018